Skip to main content
SpringerLink
Log in
Book cover

Daily Routine in Cosmetic Dermatology pp 339–351Cite as

Botulinum Toxins

  • Reference work entry
  • First Online:

  • 2250 Accesses

Part of the book series: Clinical Approaches and Procedures in Cosmetic Dermatology ((CAPCD,volume 1))

Abstract

Botulinum toxin (BoNT) has been used over the last 40 years in different medical specialties. Since then its use has been expanded over the decades to new indications, particularly in dermatology. It produces chemodenervation of muscles by inhibiting acetylcholine release on the neuromuscular junction and has been used in cosmetics to treat hyperfunctional and hyperdynamic lines and wrinkles of the face and neck as well as localized hyperhidrosis. It is currently recognized as a safe and effective treatment when standard techniques and recommended doses are used. Due to its mechanism of action, therapeutic doses are extremely small, the effect is highly precise, and systemic adverse effects are rare. There are five sources of botulinum toxin A (BoNT-A) worldwide, but BoNT formulations are not identical or interchangeable.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   299.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Ahn MS, Catten M, Maas CS. Temporal brow lift using botulinum toxin. Plast Reconstr Surg. 2000;105:1129–35.

    Article  CAS  PubMed  Google Scholar 

  • Alam M, Dover JS, Arndt KA. Pain associated with injection of botulinum toxin A exotoxin reconstituted using isotonic sodium chloride with and without preservative: a double blind, randomized controlled trial. Arch Dermatol. 2002;138:510.

    Article  CAS  PubMed  Google Scholar 

  • Alam M, Yoo SS, Wrone DA, White LE, et al. Sterility assessment of multiple use botulinum A exotoxin vials: a prospective simulation. J Am Acad Dermatol. 2006;55:272–5.

    Article  PubMed  Google Scholar 

  • Aoki RK. Pharmacology and immunology of botulinum neurotoxins. Int Ophthalmol Clin. 2005;45:25–37.

    Article  PubMed  Google Scholar 

  • Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, et al. Botulinum toxin as a biological weapon: medical and public health management. JAMA. 2001;285(8):1059–70.

    Article  CAS  PubMed  Google Scholar 

  • Asher B, Talarico S, Casuto D, Escobar S, et al. International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit) – part I: upper facial wrinkles. J Eur Acad Dermatol Venereol. 2010;24:1285–95.

    Article  Google Scholar 

  • Atamoros FP. Botulinum toxin in the lower one third of the face. Clin Dermatol. 2003;21:505–12.

    Article  PubMed  Google Scholar 

  • Bakheit AM. The possible adverse effects of intramuscular botulinum toxin injections and their management. Curr Drug Saf. 2006;1:271–9.

    Article  CAS  PubMed  Google Scholar 

  • Bentsianov B, Blitzer A. Facial anatomy. Clin Dermatol. 2004;22:3–13.

    Article  PubMed  Google Scholar 

  • Binz T, Rummel A. Cell entry strategy of clostridial neurotoxins. J Neurochem. 2009;109:1584–95.

    Article  CAS  PubMed  Google Scholar 

  • Brandt FS, Bellman B. Cosmetic use of botulinum toxin for the aging neck. Dermatol Surg. 1998;24:1232–4.

    CAS  PubMed  Google Scholar 

  • Brandt F, Bocker A. Botulinum toxin for rejuvenation of the neck. Clin Dermatol. 2001;21:513–20.

    Article  Google Scholar 

  • Callaway J. Botulinum toxin type B (Myobloc): phamacology and biochemistry. Clin Dermatol. 2004;22:22–3.

    Article  Google Scholar 

  • Carruthers J, Carruthers A. Aesthetic botulinum toxin in the mid and lower face and neck. Dermatol Surg. 2003;29:468–76.

    PubMed  Google Scholar 

  • Carruthers A, Carruthers J. Eyebrow height after botulinum toxin type A to the glabella. Dermatol Surg. 2007;33:S26–31.

    Article  CAS  PubMed  Google Scholar 

  • Carruthers A, Carruthers J. Botulinum toxin products overview. Skin Therapy Lett. 2008;13:1–4.

    CAS  PubMed  Google Scholar 

  • Carruthers J, Carruthers A. Botulinum toxin in facial rejuvenation: an update. Dermatol Clin. 2009;27:417–25.

    Article  CAS  PubMed  Google Scholar 

  • Carruthers J, Fagien S, Matarasso SL. Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg. 2004;114 (6 Suppl):1S–22S.

    Google Scholar 

  • Carruthers A, Bogle M, Carruthers JDA, Dover JS, et al. A randomized, evaluator-blinded, two-center study of the safety and effect of volume on the diffusion and efficacy of botulinum toxin type A in the treatment of lateral orbital rhytides. Dermatol Surg. 2007;33:567–71.

    CAS  PubMed  Google Scholar 

  • Chen F, Kuziemko GM, Stevens RC. Biophysical characterization of the stability of the 150-kilodalton botulinum toxin, the nontoxic component, and the 900-kilodalton botulinum toxin complex species. Infect Immun. 1998;66:2420–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Chen S, Kim JJ, Barbieri JT. Mechanism of substrate recognition by botulinum neurotoxin serotype A. J Biol Chem. 2007;282:9621–7.

    Article  CAS  PubMed  Google Scholar 

  • de Almeida AR, da Costa Marques ER, Banegas R, Kadunc BV. Glabellar contraction patterns: a tool to optimize botulinum toxin treatment. Dermatol Surg. 2012;38(9):1506–15.

    Article  PubMed  Google Scholar 

  • Elmas C, Ayhan S, Tuncer S, Erdogan D, et al. Effect of fresh and stored botulinum toxin A on muscle and nerve ultrastructure. Ann Plast Surg. 2007;59:316–22.

    Article  CAS  PubMed  Google Scholar 

  • Fagien S. Temporary management of upper lid ptosis, lid malposition, and eyelid fissure asymmetry with botulinum toxin A. Plast Reconstr Surg. 2004;114(7):1892–902.

    Article  PubMed  Google Scholar 

  • Francisco GE. Botulinum toxin: dosing and dilution. Am J Phys Med Rehabil. 2004;83:S30–70.

    Article  PubMed  Google Scholar 

  • Gartlan MG, Hoffman HT. Crystalline preparation of Botulinum toxin type A (Botox): degradation in potency with storage. Otolaryngol Head Neck Surg. 1993;108:135–40.

    Article  CAS  PubMed  Google Scholar 

  • Gassner HG, Sherris DA. Addition of an anaesthetic agent to enhance the predictability of the effects of botulinum toxin type A injections: a randomized controlled study. Mayo Clin Proc. 2000;75:701–4.

    Article  CAS  PubMed  Google Scholar 

  • Goodman G. Diffusion and Short-term efficacy of botulinum toxin A after addition of hyaluronidase and its possible application for the treatment of axillary hyperhidrosis. Dermatol Surg. 2003;29:533–8.

    PubMed  Google Scholar 

  • Greene P. Potency of frozen/thawned botulinum toxin type A in the treatment of torsion dystonia. Otolaryngol Head Neck Surg. 1993;109:968–9.

    Article  CAS  PubMed  Google Scholar 

  • Grunfeld A, Murray C, Solish N. Botulinum toxin for hyperhidrosis: a review. Am J Clin Dermatol. 2009;10:87–102.

    Article  PubMed  Google Scholar 

  • Hankins CL, Strimling R, Rogers GS. Botulinum a toxin for glabellar wrinkles. Dose Response Dermatol Surg. 1998;24:1181–3.

    CAS  PubMed  Google Scholar 

  • Hantash BM, Gladstone HB. A pilot study on the effect of epinephrine on botulinum toxin treatment for periorbital rhytides. Dermatol Surg. 2007;33:461–8.

    CAS  PubMed  Google Scholar 

  • Haubner F. Simultaneous injection of lidocaine improves predictability of effect of botulinum toxin. Laryngorrhinootologie. 2009;88:764.

    Article  CAS  Google Scholar 

  • Hexsel DM, De Almeida AT, Rutowithsch M, De Castro IA, et al. Multicenter, double blind study of the efficacy of injections with botulinum toxin type A reconstituted up to six consecutive weeks before application. Dermatol Surg. 2003;29:523.

    PubMed  Google Scholar 

  • Hexsel D, Rutowitsch MS, de Castro LC, do Prado DZ, et al. Blind multicenter study of the efficacy and safety of injections of a commercial preparation of botulinum toxin type A reconstituted up to 15 days before injection. Dermatol Surg. 2009;35:933–9.

    Article  CAS  PubMed  Google Scholar 

  • Huang W, Rogachefsky AS, Foster JA. Brow lift with botulinum toxin. Dermatol Surg. 2000;26:55–60.

    Article  CAS  PubMed  Google Scholar 

  • Hui JI, Wendy WL. Efficacy of fresh versus refrigerated botulinum toxin in the treatment of lateral periorbital rhytids. Ophthal Plast Reconstr Surg. 2007;23:433–8.

    Article  PubMed  Google Scholar 

  • Huilgol SC, Carruthers A, Carruthers JDA. Raising eyebrows with botulinum toxin. Dermatol Surg. 1999;25:373–6.

    Article  CAS  PubMed  Google Scholar 

  • Jabor MA, Kaushik R, Shayani P, Ruiz-Razura A, et al. Efficacy of reconstituted and stored Botulinum toxin Type A: an electrophysiologic study in the auricular muscle of the rabbit. Plast Reconstr Surg. 2003;111:2419–26.

    Article  PubMed  Google Scholar 

  • Kane M. Discussion on reconstituted botulinum type A neurotoxin: clinical efficacy after long-term freezing before use. Aesth Plast Surg. 2007;31:192–3.

    Article  Google Scholar 

  • Kane M, Donofrio L, Ascher B, Hexsel D, et al. Expanding the use of neurotoxins in facial aesthetics: a consensus panel’s assessment and recommendations. J Drugs Dermatol. 2010;9:S7–22.

    PubMed  Google Scholar 

  • Kazim NA, Black EH. Botox: shaken, not stirred. Ophthal Plast Reconstr Surg. 2008;24:10–2.

    Article  PubMed  Google Scholar 

  • Kenner JR. Hyaluronic acid filler and botulinum neurotoxin delivered simultaneously in the same syringe for effective and convenient combination aesthetic rejuvenation therapy. J Drug Dermatol. 2010;9:1135–8.

    Google Scholar 

  • Klein AW. Dilution and storage of botulinum toxin. Dermatol Surg. 1998;24:1179–80.

    CAS  PubMed  Google Scholar 

  • Klein AW. Complications. Adverse reactions and insights with the use of botulinum toxin. Dermatol Surg. 2003;29(5):549–56.

    PubMed  Google Scholar 

  • Klein AW. Contraindications and complications with the use of botulinum toxin. Clin Dermatol. 2004;22:66–75.

    Article  PubMed  Google Scholar 

  • Klein AW, Kreydenb OP. Storage and dilution of botulinum toxin. In: Kreyden OP, Böni R, Burg G, editors. Hyperhidrosis and botulinum toxin in dermatology, Current problems in dermatology, vol. 30. Basel: Karger; 2002. p. 126–30.

    Chapter  Google Scholar 

  • Kreyden O. Botulinum toxin in the management of focal hyperhidrosis. In: Benedetto A, editor. Botulinum toxin in clinical dermatology, vol. 10. London: Taylor and Francis; 2006. p. 278–9.

    Google Scholar 

  • Kwiat DM, Bersani TA, Bersani A. Increased patient comfort utilizing botulinum toxin type A reconstituted with preserved versus nonpreserved saline. Ophthal Plast Reconstr Surg. 2004;20:186–9.

    Article  PubMed  Google Scholar 

  • Le Louarn C. Botulinum toxin A and facial lines: the variable concentration. Aesthet Plast Surg. 2001;25:73–84.

    Article  Google Scholar 

  • Li M, Goldberger BA, Carolyn H. Fatal case of Botox-related anaphylaxis? J Forensic Sci. 2005;50:169–72.

    PubMed  Google Scholar 

  • Lizarralde M, Gutierrez SH, Venegas A. Clinical efficacy of botulinum toxin type A reconstituted and refrigerated 1 week before its application in external canthus dynamic lines. Dermatol Surg. 2007;33:1328–33.

    CAS  PubMed  Google Scholar 

  • Mantel A. Dilution, storage, and electromyographic guidance in the use of botulinum toxins. Dermatol Clin. 2004;22:135–6.

    Article  Google Scholar 

  • Menon J, Murray A. Microbial growth in vials of Botulinum toxin following use in clinic. Eye. 2007;21:995–7.

    Article  CAS  PubMed  Google Scholar 

  • Moore P, Naumann M. General and clinical aspect of treatment with botulinum toxin. In: Moore P, Naumann M, editors. Handbook of botulinum toxin treatment, vol. 3. 2nd ed. Malden: Blackwell Science; 2003. p. 41.

    Google Scholar 

  • Package insert on Botox. Irvine:, Allergan, Inc; Oct 2010.

    Google Scholar 

  • Package insert on BTXA, downloaded from www.btxa.com. Lanzhou Institute of Biological Products (LIBP). Accessed 1 Oct 2015.

  • Package insert on Dysport. Berkshire: Beauford-Ipsen Ltda.; May 2009.

    Google Scholar 

  • Package insert on Myobloc. San Diego: Elan Pharmaceuticals; Sept 2009.

    Google Scholar 

  • Package insert on Prosigne. Distributed by Cristalia in Brazil. Lanzhou, China 2005.

    Google Scholar 

  • Package insert on Xeomin. Germany: Merz Pharma GmbH & Co; 2010.

    Google Scholar 

  • Parrish J. Commercial preparations and handling of botulinum toxin type A and type B. Clin Dermatol. 2003;21:481–4.

    Article  Google Scholar 

  • Parsa AA, Lye KD, Parsa FD. Reconstituted botulinum type A neurotoxin: clinical efficacy after long-term freezing before use. Aesth Plast Surg. 2007;31:188–91.

    Article  Google Scholar 

  • Poulain B, Popoff M, Molgo J. How do the botulinum neurotoxins block neurotransmitter release: from botulism to the molecular mechanism of action. Botulinum J. 2008;1:14–87.

    Article  Google Scholar 

  • Redaelli A, Forte R. Botulinum toxin dilution: our technique. J Cosmet Laser Ther. 2003;5:218–9.

    Article  CAS  PubMed  Google Scholar 

  • Sadick N. The cosmetic use of botulinum toxin type B in the upper face. Clin Dermatol. 2004;22:29–33.

    Article  PubMed  Google Scholar 

  • Salashe S, Bernstein G, Senkarik M. Regional anatomy: lip. In: Salashe S, Bernstein G, Senkarik M, editors. Surgical anatomy of the skin, vol. 18. Norwalk: Appleton & Lange; 1998. p. 223–40.

    Google Scholar 

  • Sarifakioglu N, Sarifakioglu E. Evaluating effects of preservative-containing saline solution on pain perception during botulinum toxin type A injections at different locations: a prospective, single-blinded, randomized controlled trial. Aesth Plast Surg. 2005;29:113–5.

    Article  Google Scholar 

  • Sattler G. Current and future botulinum neurotoxin type A preparations in aesthetics: a literature review. J Drugs Dermatol. 2010;9:1065–71.

    PubMed  Google Scholar 

  • Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. J Pediatr Ophthalmol Strabismus. 1980;17:21–5.

    CAS  PubMed  Google Scholar 

  • Semchyshyn N, Sengelmann RD. Botulinum toxin a treatment for perioral rhytides. Dermatol Surg. 2003;29(5):490–5.

    PubMed  Google Scholar 

  • Setler P. The biochemistry of botulinum toxin type B. Neurology. 2000;55:S22–8.

    Article  CAS  PubMed  Google Scholar 

  • Sharma SK, Singh BR. Hemagglutinin binding mediated protection of botulinum neurotoxin from proteolysis. J Nat Toxins. 1998;7:239–53.

    CAS  PubMed  Google Scholar 

  • Shin HI, Han TR, Seo KI. Effects of dilution volume of botulinum toxin A. J Korean Acad Phys Med Rehab. 2000;28:67.

    Google Scholar 

  • Shome D, Nair AG, Kapoor R, Jain V. Botulinum toxin A: is it really a fragile molecule? Dermatol Surg. 2010;36:2106–10.

    Article  CAS  PubMed  Google Scholar 

  • Singer C, Weiner WJ. Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes. Muscle Nerve. 1993;16(6):677.

    Article  CAS  PubMed  Google Scholar 

  • Sloop RR, Cole BA, Escutin RO. Reconstituted botulinum toxin type A does not loose potency in humans if re-frozen or refrigerated for 2 weeks before use. Neurology. 1997;48:149.

    Article  Google Scholar 

  • Sommer B. How to avoid complications when treating hyperdynamic folds and wrinkles. Clin Dermatol. 2003;21:521–3.

    Article  PubMed  Google Scholar 

  • Talarico Filho S, Nascimento M, Macedo F, Pe’cora C. A double-blind, randomized, comparative study of two type A botulinum toxins in the treatment of primary axillary hyperhidrosis. Dermatol Surg. 2007;33:S44–50.

    Article  CAS  PubMed  Google Scholar 

  • Thomas JP, Siupsinskiene N. Frozen versus fresh reconstituted botox for laryngeal dystonia. Otolaryngol Head Neck Surg. 2006;135:204–8.

    Article  PubMed  Google Scholar 

  • Toth SI, Smith LA, Ahmed SA. Extreme sensitivity of botulinum neurotoxin domains towards mild agitation. J Pharm Sci. 2009;98:3302–11.

    Article  CAS  PubMed  Google Scholar 

  • Trindade de Almeida AR, Kadunc BV, Di Chiacchio N, Neto DR. Foam during reconstitution does not affect the potency of Botulinum toxin A. Dermatol Surg. 2003;29:530.

    Article  PubMed  Google Scholar 

  • Trindade De Almeida AR, Secco LC, Carruthers A. Handling botulinum toxins: an updated literature review. Dermatol Surg. 2011;37(11):1553–65.

    Article  CAS  PubMed  Google Scholar 

  • Vadoud-Seyedi J, Simonart T. Treatment of axillary hyperhidrosis with botulinum toxin type a reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study. Br J Dermatol. 2007;156:986–9.

    Article  CAS  PubMed  Google Scholar 

  • Wollina U, Konrad H. Managing adverse events associated with botulinum toxin type A. Am J Clin Dermatol. 2005;6:141–50.

    Article  PubMed  Google Scholar 

  • Yang GC, Chiu RJ, Gillman GS. Questioning the need to use Botox within 4 hours of reconstitution: a study of fresh vs 2-weekold Botox. Arch Facial Plast Surg. 2008;10:273–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hospital do Servidor Público Municipal de São Paulo, São Paulo, SP, Brazil

    Ada Regina Trindade de Almeida & Yanna Kelly Silva

Authors
  1. Ada Regina Trindade de Almeida
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yanna Kelly Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ada Regina Trindade de Almeida .

Editor information

Editors and Affiliations

  1. Department of Clinical Medicine – Dermatology, Fluminense Federal University, Niterói, Rio de Janeiro, Brazil

    Maria Claudia Almeida Issa

  2. Clínicas Hospital of São Paulo of the University of Sao Paulo, Sao Paulo, São Paulo, Brazil

    Bhertha Tamura

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this entry

Cite this entry

Trindade de Almeida, A.R., Silva, Y.K. (2017). Botulinum Toxins. In: Issa, M., Tamura, B. (eds) Daily Routine in Cosmetic Dermatology. Clinical Approaches and Procedures in Cosmetic Dermatology, vol 1. Springer, Cham. https://doi.org/10.1007/978-3-319-12589-3_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-12589-3_32

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-12588-6

  • Online ISBN: 978-3-319-12589-3

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation